143 related articles for article (PubMed ID: 10458414)
21. Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies.
Aghi M; Kramm CM; Chou TC; Breakefield XO; Chiocca EA
J Natl Cancer Inst; 1998 Mar; 90(5):370-80. PubMed ID: 9498487
[TBL] [Abstract][Full Text] [Related]
22. Recombinant interleukin-2 enhanced the antitumor effect of ADV/RSV-HSV-tk/ACV therapy in a murine bladder cancer model.
Terao S; Shirakawa T; Goda K; Kamidono S; Fujisawa M; Gotoh A
Anticancer Res; 2005; 25(4):2757-60. PubMed ID: 16080522
[TBL] [Abstract][Full Text] [Related]
23. Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine.
Lawrence TS; Rehemtulla A; Ng EY; Wilson M; Trosko JE; Stetson PL
Cancer Res; 1998 Jun; 58(12):2588-93. PubMed ID: 9635583
[TBL] [Abstract][Full Text] [Related]
24. Dose of adenoviral vectors expressing interleukin-2 plays an important role in combined gene therapy with cytosine deaminase/5-fluorocytosine: preclinical consideration.
Nakamori M; Iwahashi M; Ueda K; Tsunoda T; Terasawa H; Hamada H; Yamaue H
Jpn J Cancer Res; 2002 Jun; 93(6):706-15. PubMed ID: 12079520
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
Anello R; Cohen S; Atkinson G; Hall SJ
J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated thymidine kinase gene therapy induces apoptosis in human epithelial ovarian cancer cells and damages PARP-1.
Kieback DG
In Vivo; 2009; 23(1):77-80. PubMed ID: 19368128
[TBL] [Abstract][Full Text] [Related]
27. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
[TBL] [Abstract][Full Text] [Related]
28. Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity.
Blackburn RV; Galoforo SS; Corry PM; Lee YJ
Int J Cancer; 1999 Jul; 82(2):293-7. PubMed ID: 10389766
[TBL] [Abstract][Full Text] [Related]
29. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity.
Rogulski KR; Kim JH; Kim SH; Freytag SO
Hum Gene Ther; 1997 Jan; 8(1):73-85. PubMed ID: 8989997
[TBL] [Abstract][Full Text] [Related]
30. In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy.
Shirakawa T; Ko SC; Gardner TA; Cheon J; Miyamoto T; Gotoh A; Chung LW; Kao C
Cancer Gene Ther; 1998; 5(5):274-80. PubMed ID: 9824046
[TBL] [Abstract][Full Text] [Related]
31. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
[TBL] [Abstract][Full Text] [Related]
32. Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells.
Pederson LC; Vickers SM; Buchsbaum DJ; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
J Gastrointest Surg; 1998; 2(3):283-91. PubMed ID: 9841986
[TBL] [Abstract][Full Text] [Related]
33. [The killing effects of two prodrug sensitivity genes on human pancreatic carcinoma cells PC-2].
Zhang L; Liu T; Cui Q
Zhonghua Bing Li Xue Za Zhi; 1998 Dec; 27(6):412-5. PubMed ID: 11244949
[TBL] [Abstract][Full Text] [Related]
34. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
[TBL] [Abstract][Full Text] [Related]
35. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
[TBL] [Abstract][Full Text] [Related]
36. Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model.
Cheon J; Ko SC; Gardner TA; Shirakawa T; Gotoh A; Kao C; Chung LW
Cancer Gene Ther; 1997; 4(6):359-65. PubMed ID: 9408606
[TBL] [Abstract][Full Text] [Related]
37. A potential therapeutic strategy to combat leukemia virus infection.
Pan J; Zhong C; Chang Z; Roy-Burman P
Cancer Biol Ther; 2003; 2(1):92-9. PubMed ID: 12673127
[TBL] [Abstract][Full Text] [Related]
38. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
[TBL] [Abstract][Full Text] [Related]
39. Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with 19F-NMR spectroscopy.
Corban-Wilhelm H; Hull WE; Becker G; Bauder-Wüst U; Greulich D; Debus J
Gene Ther; 2002 Dec; 9(23):1564-75. PubMed ID: 12424609
[TBL] [Abstract][Full Text] [Related]
40. Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.
Zhang M; Li S; Nyati MK; DeRemer S; Parsels J; Rehemtulla A; Ensminger WD; Lawrence TS
Cancer Res; 2003 Feb; 63(3):658-63. PubMed ID: 12566311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
